Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.66 +0.01 (+1.71%)
At close: Sep 30, 2026 · 4:00 PM EDT

Biodexa Pharmaceuticals (BDRX) Non-cash Items (2013 - 2016)

Updated

Biodexa Pharmaceuticals (BDRX) recorded Non-cash Items of -$10.57 million in the year ended Dec 31, 2025, compared with -$11.06 million a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Non-cash Items (2013 - 2016) Analysis & Trends

Starting with the year ended Dec 31, 2013, Biodexa Pharmaceuticals' Non-cash Items history includes 13 years.

  • Annual Non-cash Items has ranged from -$11.06 million in the year ended Dec 31, 2024 to -$9.01 million in the year ended Dec 31, 2021 over the past five years.
  • Per Business Quant data, BDRX's Non-cash Items was -$11.06 million in the year ended Dec 31, 2024, -$9.48 million in the year ended Dec 31, 2023, -$10.21 million in the year ended Dec 31, 2022 and -$9.01 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Biodexa Pharmaceuticals 41.06 Mn 17.85 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -18.17 Mn
Dec 31, 2015 -18.48 Mn
Dec 31, 2014 -11.84 Mn
Dec 31, 2013 -6.88 Mn
API Access

Biodexa Pharmaceuticals Non-cash Items API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-cash-items&ticker=BDRX&period=max&api_key=YOUR_API_KEY